vs

Side-by-side financial comparison of Chime Financial, Inc. (CHYM) and HEALTHCARE SERVICES GROUP INC (HCSG). Click either name above to swap in a different company.

Chime Financial, Inc. is the larger business by last-quarter revenue ($543.5M vs $466.7M, roughly 1.2× HEALTHCARE SERVICES GROUP INC). On growth, Chime Financial, Inc. posted the faster year-over-year revenue change (28.8% vs 6.6%). HEALTHCARE SERVICES GROUP INC produced more free cash flow last quarter ($16.0M vs $15.4M).

Chime Financial, Inc. is an American financial technology company based in San Francisco, California. It provides fee-free mobile banking services through two national banks, Stride Bank and The Bancorp Bank.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

CHYM vs HCSG — Head-to-Head

Bigger by revenue
CHYM
CHYM
1.2× larger
CHYM
$543.5M
$466.7M
HCSG
Growing faster (revenue YoY)
CHYM
CHYM
+22.2% gap
CHYM
28.8%
6.6%
HCSG
More free cash flow
HCSG
HCSG
$580.0K more FCF
HCSG
$16.0M
$15.4M
CHYM

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CHYM
CHYM
HCSG
HCSG
Revenue
$543.5M
$466.7M
Net Profit
$-54.7M
Gross Margin
87.2%
15.4%
Operating Margin
-11.9%
6.1%
Net Margin
-10.1%
Revenue YoY
28.8%
6.6%
Net Profit YoY
-148.4%
EPS (diluted)
$-0.15
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHYM
CHYM
HCSG
HCSG
Q4 25
$466.7M
Q3 25
$543.5M
$464.3M
Q2 25
$528.1M
$458.5M
Q1 25
$447.7M
Q4 24
$437.8M
Q3 24
$421.9M
$428.1M
Q2 24
$384.2M
$426.3M
Q1 24
$423.4M
Net Profit
CHYM
CHYM
HCSG
HCSG
Q4 25
Q3 25
$-54.7M
$43.0M
Q2 25
$-923.4M
$-32.4M
Q1 25
$17.2M
Q4 24
Q3 24
$-22.0M
$14.0M
Q2 24
$385.0K
$-1.8M
Q1 24
$15.3M
Gross Margin
CHYM
CHYM
HCSG
HCSG
Q4 25
15.4%
Q3 25
87.2%
20.8%
Q2 25
87.3%
0.6%
Q1 25
15.2%
Q4 24
13.4%
Q3 24
87.3%
14.8%
Q2 24
86.9%
9.7%
Q1 24
15.2%
Operating Margin
CHYM
CHYM
HCSG
HCSG
Q4 25
6.1%
Q3 25
-11.9%
12.3%
Q2 25
-176.2%
-9.1%
Q1 25
5.3%
Q4 24
3.4%
Q3 24
-7.3%
4.4%
Q2 24
-2.5%
-0.5%
Q1 24
5.0%
Net Margin
CHYM
CHYM
HCSG
HCSG
Q4 25
Q3 25
-10.1%
9.3%
Q2 25
-174.8%
-7.1%
Q1 25
3.8%
Q4 24
Q3 24
-5.2%
3.3%
Q2 24
0.1%
-0.4%
Q1 24
3.6%
EPS (diluted)
CHYM
CHYM
HCSG
HCSG
Q4 25
$0.43
Q3 25
$-0.15
$0.59
Q2 25
$-7.29
$-0.44
Q1 25
$0.23
Q4 24
$0.15
Q3 24
$-0.34
$0.19
Q2 24
$0.00
$-0.02
Q1 24
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHYM
CHYM
HCSG
HCSG
Cash + ST InvestmentsLiquidity on hand
$445.0M
$168.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$510.2M
Total Assets
$2.0B
$794.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHYM
CHYM
HCSG
HCSG
Q4 25
$168.0M
Q3 25
$445.0M
$177.5M
Q2 25
$868.3M
$134.5M
Q1 25
$114.8M
Q4 24
$107.3M
Q3 24
$270.8M
$103.8M
Q2 24
$295.4M
$105.6M
Q1 24
$104.9M
Stockholders' Equity
CHYM
CHYM
HCSG
HCSG
Q4 25
$510.2M
Q3 25
$1.4B
$496.0M
Q2 25
$1.4B
$477.0M
Q1 25
$514.2M
Q4 24
$499.9M
Q3 24
$-1.9B
$488.7M
Q2 24
$-1.9B
$471.4M
Q1 24
$474.6M
Total Assets
CHYM
CHYM
HCSG
HCSG
Q4 25
$794.3M
Q3 25
$2.0B
$804.3M
Q2 25
$1.9B
$802.2M
Q1 25
$823.0M
Q4 24
$802.8M
Q3 24
$805.8M
Q2 24
$799.7M
Q1 24
$803.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHYM
CHYM
HCSG
HCSG
Operating Cash FlowLast quarter
$17.5M
$17.4M
Free Cash FlowOCF − Capex
$15.4M
$16.0M
FCF MarginFCF / Revenue
2.8%
3.4%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$139.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHYM
CHYM
HCSG
HCSG
Q4 25
$17.4M
Q3 25
$17.5M
$71.3M
Q2 25
$2.7M
$28.8M
Q1 25
$27.5M
Q4 24
$36.2M
Q3 24
$4.3M
Q2 24
$16.3M
Q1 24
$-26.0M
Free Cash Flow
CHYM
CHYM
HCSG
HCSG
Q4 25
$16.0M
Q3 25
$15.4M
$70.0M
Q2 25
$-888.0K
$27.4M
Q1 25
$25.8M
Q4 24
$34.8M
Q3 24
$2.9M
Q2 24
$15.0M
Q1 24
$-28.2M
FCF Margin
CHYM
CHYM
HCSG
HCSG
Q4 25
3.4%
Q3 25
2.8%
15.1%
Q2 25
-0.2%
6.0%
Q1 25
5.8%
Q4 24
7.9%
Q3 24
0.7%
Q2 24
3.5%
Q1 24
-6.7%
Capex Intensity
CHYM
CHYM
HCSG
HCSG
Q4 25
0.3%
Q3 25
0.4%
0.3%
Q2 25
0.7%
0.3%
Q1 25
0.4%
Q4 24
0.3%
Q3 24
0.3%
Q2 24
0.3%
Q1 24
0.5%
Cash Conversion
CHYM
CHYM
HCSG
HCSG
Q4 25
Q3 25
1.66×
Q2 25
Q1 25
1.60×
Q4 24
Q3 24
0.31×
Q2 24
Q1 24
-1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHYM
CHYM

Payments Revenue$363.2M67%
Platform Related Revenue$180.4M33%

HCSG
HCSG

Dietary Services$255.9M55%
Other$210.8M45%

Related Comparisons